These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3865456

  • 1. Recognition of DP determinants with typing reagents prepared with lymphocytes from Dutch unrelated individuals.
    Termijtelen A, Naipal-van den Berge S, Suwandi-Thung L, van Rood JJ.
    Tissue Antigens; 1985 Oct; 26(4):234-42. PubMed ID: 3865456
    [Abstract] [Full Text] [Related]

  • 2. The HLA-DP polymorphism in Denmark investigated by local and international PLT reagents. Definition of two "new" DP antigens.
    Odum N, Hartzman R, Jakobsen BK, Morling N, Platz P, Robbins FM, Ryder LP, Svejgaard A.
    Tissue Antigens; 1986 Aug; 28(2):105-18. PubMed ID: 2428128
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Correlation between HLA-D/DR associated primed lymphocyte typing (PLT) defined DP-antigens, HLA-D and HLA-DR antigens.
    Morling N, Jakobsen BK, Platz P, Ryder LP, Svejgaard A, Thomsen M.
    Tissue Antigens; 1981 Aug; 17(4):421-7. PubMed ID: 7036403
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Positive correlation between oligonucleotide typing and T-cell recognition of HLA-DP molecules.
    de Koster HS, Kenter MJ, D'Amaro J, Luiten RM, Schroeijers WE, Giphart MJ, Termijtelen A.
    Immunogenetics; 1991 Aug; 34(1):12-22. PubMed ID: 1713190
    [Abstract] [Full Text] [Related]

  • 8. Cellular and serological subtypes of HLA-DR2.
    Freidel AC, Betuel H, Gebuhrer L, Farre A, Lambert J.
    Tissue Antigens; 1987 Mar; 29(3):129-40. PubMed ID: 2955548
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Typing for HLA-D/DR associated DP-antigens with the primed lymphocyte typing (PLT) technique.
    Morling N, Jakobsen BK, Platz P, Ryder LP, Svejgaard A, Thomsen M.
    Tissue Antigens; 1980 May; 15(5):471-82. PubMed ID: 6449760
    [Abstract] [Full Text] [Related]

  • 11. Selection of unrelated bone marrow donors: does the current procedure warrant complete MHC class II identity?
    Eiermann TH, Ballas M, Fakler J, Müller C, Wölpl A, Goldmann SF.
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):127-9. PubMed ID: 1498553
    [Abstract] [Full Text] [Related]

  • 12. An HLA-DR/DP recombinant family involving DPw6. Evidence for cross-reactivity between DPw6 and GNN2B.
    Odum N, Hartzman R, Jakobsen BK, Morling N, Platz P, Robbins FM, Ryder LP, Shaw S, Svejgaard A.
    Tissue Antigens; 1986 Jan; 27(1):44-52. PubMed ID: 3082036
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Detection of HLA-D region products by primed lymphocyte typing (PLT).
    Moen T, Nousiainen H, Bratlie A, Solheim BG, Thorsby E.
    Hum Immunol; 1981 Jul; 2(4):287-94. PubMed ID: 6944298
    [Abstract] [Full Text] [Related]

  • 15. A study of HLA-DR2 associated HLA-Dw/LD specificities.
    Reinsmoen NL, Layrisse Z, Betuel H, Freidel AC, Bach FH.
    Hum Immunol; 1984 Oct; 11(2):105-15. PubMed ID: 6208174
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of human class II antigens by cloned cytolytic T cell reagents: a study using HLA loss mutant lymphoblastoid cell lines and monoclonal antibodies detecting the HLA-DP product(s).
    Ohta N, Anichini A, Reinsmoen NL, Strassmann G, Wernet P, Bach FH.
    Hum Immunol; 1985 May; 13(1):21-32. PubMed ID: 3872867
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.